Bone turnover markers: basic biology to clinical applications
M Schini, T Vilaca, F Gossiel, S Salam… - Endocrine …, 2023 - academic.oup.com
Bone turnover markers (BTMs) are used widely, in both research and clinical practice. In the
last 20 years, much experience has been gained in measurement and interpretation of these …
last 20 years, much experience has been gained in measurement and interpretation of these …
Associations between hemodialysis access type and clinical outcomes: a systematic review
P Ravani, SC Palmer, MJ Oliver… - Journal of the …, 2013 - journals.lww.com
Clinical practice guidelines recommend an arteriovenous fistula as the preferred vascular
access for hemodialysis, but quantitative associations between vascular access type and …
access for hemodialysis, but quantitative associations between vascular access type and …
Serum levels of phosphorus, parathyroid hormone, and calcium and risks of death and cardiovascular disease in individuals with chronic kidney disease: a systematic …
SC Palmer, A Hayen, P Macaskill, F Pellegrini… - Jama, 2011 - jamanetwork.com
Context Clinical practice guidelines on the management of mineral and bone disorders due
to chronic kidney disease recommend specific treatment target levels for serum phosphorus …
to chronic kidney disease recommend specific treatment target levels for serum phosphorus …
Bicarbonate supplementation slows progression of CKD and improves nutritional status
I de Brito-Ashurst, M Varagunam… - Journal of the …, 2009 - journals.lww.com
Bicarbonate supplementation preserves renal function in experimental chronic kidney
disease (CKD), but whether the same benefit occurs in humans is unknown. Here, we …
disease (CKD), but whether the same benefit occurs in humans is unknown. Here, we …
Alkaline phosphatase: an old friend as treatment target for cardiovascular and mineral bone disorders in chronic kidney disease
M Haarhaus, G Cianciolo, S Barbuto, G La Manna… - Nutrients, 2022 - mdpi.com
Alkaline phosphatase (ALP) is an evolutionary conserved enzyme and widely used
biomarker in clinical practice. Tissue-nonspecific alkaline phosphatase (TNALP) is one of …
biomarker in clinical practice. Tissue-nonspecific alkaline phosphatase (TNALP) is one of …
Chronic kidney disease
P Drawz, M Rahman - Annals of internal medicine, 2015 - acpjournals.org
This issue provides a clinical overview of chronic kidney disease, focusing on prevention,
diagnosis, treatment, and patient information. The content of In the Clinic is drawn from the …
diagnosis, treatment, and patient information. The content of In the Clinic is drawn from the …
[HTML][HTML] Doença renal crônica: importância do diagnóstico precoce, encaminhamento imediato e abordagem interdisciplinar estruturada para melhora do desfecho …
MG Bastos, GM Kirsztajn - Brazilian Journal of Nephrology, 2011 - SciELO Brasil
Atualmente, é amplamente aceita a definição da doença renal crônica (DRC) que se baseia
em alterações na taxa de filtração glomerular e/ou presença de lesão parenquimatosa …
em alterações na taxa de filtração glomerular e/ou presença de lesão parenquimatosa …
Effect of vitamin D on blood pressure: a systematic review and meta-analysis
Objectives Vitamin D insufficiency has been linked to hypertension and cardiovascular
events in observational studies. It is unclear whether vitamin D supplementation can reduce …
events in observational studies. It is unclear whether vitamin D supplementation can reduce …
Effect of paricalcitol on left ventricular mass and function in CKD—the OPERA trial
AYM Wang, F Fang, J Chan, YY Wen… - Journal of the …, 2014 - journals.lww.com
Vitamin D seems to protect against cardiovascular disease, but the reported effects of
vitamin D on patient outcomes in CKD are controversial. We conducted a prospective …
vitamin D on patient outcomes in CKD are controversial. We conducted a prospective …
Risk prediction models for patients with chronic kidney disease: a systematic review
Background: Patients with chronic kidney disease (CKD) are at increased risk for kidney
failure, cardiovascular events, and all-cause mortality. Accurate models are needed to …
failure, cardiovascular events, and all-cause mortality. Accurate models are needed to …